| Identification | Back Directory | [Name]
(3β,4β,17β)-17-(2-Pyridinylmethyl)androst-5-ene-3,4,17-triol | [CAS]
1393651-00-7 | [Synonyms]
(3β,4β,17β)-17-(2-Pyridinylmethyl)androst-5-ene-3,4,17-triol | [Molecular Formula]
C25H35NO3 | [MOL File]
1393651-00-7.mol | [Molecular Weight]
397.55 |
| Chemical Properties | Back Directory | [Boiling point ]
550.386±50.00 °C(Press: 760.00 Torr)(predicted) | [density ]
1.228±0.10 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | [solubility ]
DMSO: Soluble: =10 mg/ml
Ethanol: Soluble: =10 mg/mlPBS (pH 7.2): Slightly soluble: 0.1-1 mg/ml | [pka]
14.271±0.70(predicted) |
| Hazard Information | Back Directory | [Uses]
(3β,4β,17β)-17-(2-Pyridinylmethyl)androst-5-ene-3,4,17-triol is an androstane derivative with anticancer activity[1]. | [References]
[1] ?esti? TL, et al. In silico ADMET analysis of the A-, B- and D-modified androstane derivatives with potential anticancer effects. Steroids. 2023 Jan;189:109147. DOI:10.1016/j.steroids.2022.109147 |
|
|